Review
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 6, 2022; 10(28): 9970-9984
Published online Oct 6, 2022. doi: 10.12998/wjcc.v10.i28.9970
COVID-19 and the heart
Andrew Xanthopoulos, Angeliki Bourazana, Grigorios Giamouzis, Evangelia Skoularigki, Apostolos Dimos, Alexandros Zagouras, Michail Papamichalis, Ioannis Leventis, Dimitrios E Magouliotis, Filippos Triposkiadis, John Skoularigis
Andrew Xanthopoulos, Angeliki Bourazana, Grigorios Giamouzis, Evangelia Skoularigki, Apostolos Dimos, Alexandros Zagouras, Michail Papamichalis, Ioannis Leventis, Filippos Triposkiadis, John Skoularigis, Department of Cardiology, University Hospital of Larissa, Larissa 41110, Greece
Dimitrios E Magouliotis, Department of Cardiothoracic Surgery, University of Thessaly, Larissa Biopolis, Larissa 41110, Greece
Author contributions: All authors made substantial contributions to conception and design of the study, acquisition of data or analysis and interpretation of data, drafted the article or made critical revisions related to important intellectual content of the manuscript, and gave final approval of the version of the article to be published.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Andrew Xanthopoulos, FACC, MD, PhD, Doctor, Department of Cardiology, University Hospital of Larissa, Mezourlo, Larissa 41110, Greece. andrewvxanth@gmail.com
Received: March 23, 2022
Peer-review started: March 23, 2022
First decision: June 16, 2022
Revised: July 27, 2022
Accepted: August 24, 2022
Article in press: August 24, 2022
Published online: October 6, 2022
Processing time: 188 Days and 2.3 Hours
Core Tip

Core Tip: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) disease. Although SARS-CoV-2 infection predominantly offends the respiratory system, it leads to various cardiovascular complications as well. SARS-CoV-2 infected patients with a history of cardiovascular disease exhibit poor outcomes. The main COVID-19 related cardiovascular complications include acute coronary syndromes, myocarditis, heart failure and arrhythmias.